Bank of Nova Scotia Trust’s Pfizer PFE Stock Holding History

Bank of Nova Scotia Trust’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$303K	Buy	10,773 +2,659	+33%	+$70.8K	0.03%	133
2025 Q4	$202K	Sell	8,114 -304	-4%	-$7.67K	0.02%	158
2025 Q3	$214K	Hold	8,418	–	–	0.02%	124
2025 Q2	$204K	Buy	8,418 +169	+2%	+$3.94K	0.02%	121
2025 Q1	$209K	Buy	8,249 +496	+6%	+$13K	0.02%	123
2024 Q4	$206K	Sell	7,753 -3,301	-30%	-$89.5K	0.02%	127
2024 Q3	$320K	Buy	11,054 +1,256	+13%	+$36.6K	0.03%	113
2024 Q2	$274K	Buy	9,798 +85	+0.9%	+$2.34K	0.03%	115
2024 Q1	$270K	Sell	9,713 -39	-0.4%	-$1.08K	0.03%	119
2023 Q4	$281K	Sell	9,752 -1,011	-9%	-$30.6K	0.03%	114
2023 Q3	$357K	Sell	10,763 -1,215	-10%	-$43K	0.04%	108
2023 Q2	$439K	Sell	11,978 -571	-5%	-$22.2K	0.05%	103
2023 Q1	$512K	Sell	12,549 -11,095	-47%	-$479K	0.06%	95
2022 Q4	$1.21M	Sell	23,644 -16,287	-41%	-$781K	0.13%	69
2022 Q3	$1.75M	Sell	39,931 -80,591	-67%	-$3.92M	0.2%	58
2022 Q2	$6.32M	Sell	120,522 -12,971	-10%	-$661K	0.65%	41
2022 Q1	$6.91M	Sell	133,493 -42,900	-24%	-$2.23M	0.6%	42
2021 Q4	$10.4M	Sell	176,393 -1,273	-0.7%	-$63.1K	0.9%	37
2021 Q3	$7.64M	Sell	177,666 -1,676	-0.9%	-$74.2K	0.69%	43
2021 Q2	$7.02M	Buy	179,342 +235	+0.1%	+$9.14K	0.62%	45
2021 Q1	$6.49M	Buy	179,107 +49,251	+38%	+$1.75M	0.62%	45
2020 Q4	$4.78M	Buy	129,856 +40,338	+45%	+$1.48M	0.5%	48
2020 Q3	$3.12M	Buy	89,518 +4,838	+6%	+$170K	0.38%	49
2020 Q2	$2.63M	Buy	84,680 +4,838	+6%	+$164K	0.39%	45
2020 Q1	$2.47M	Buy	79,842 +10,261	+15%	+$350K	0.37%	49
2019 Q4	$2.59M	Buy	69,581 +12,730	+22%	+$453K	0.29%	52
2019 Q3	$1.94M	Buy	56,851 +24,751	+77%	+$900K	0.23%	55
2019 Q2	$1.32M	Sell	32,100 -8,718	-21%	-$346K	0.16%	62
2019 Q1	$1.64M	Buy	40,818 +141	+0.3%	+$5.65K	0.2%	58
2018 Q4	$1.69M	Sell	40,677 -731	-2%	-$30.3K	0.23%	58
2018 Q3	$1.73M	Sell	41,408 -144	-0.3%	-$5.54K	0.19%	59
2018 Q2	$1.43M	Sell	41,552 -661	-2%	-$22.6K	0.16%	61
2018 Q1	$1.42M	Buy	42,213 +1,481	+4%	+$50.9K	0.17%	60
2017 Q4	$1.4M	Sell	40,732 -81,574	-67%	-$2.78M	0.15%	65
2017 Q3	$4.14M	Buy	122,306 +1,019	+0.8%	+$32.8K	0.44%	43
2017 Q2	$3.87M	Sell	121,287 -7,285	-6%	-$230K	0.44%	43
2017 Q1	$4.17M	Buy	128,572 +2,601	+2%	+$82K	0.47%	41
2016 Q4	$3.88M	Sell	125,971 -1,864	-1%	-$56.9K	0.44%	43
2016 Q3	$4.11M	Sell	127,835 -36,197	-22%	-$1.21M	0.49%	39
2016 Q2	$5.48M	Sell	164,032 -14,323	-8%	-$457K	0.72%	31
2016 Q1	$5.01M	Sell	178,355 -47,013	-21%	-$1.34M	0.68%	35
2015 Q4	$6.9M	Sell	225,368 -129,842	-37%	-$4.08M	1.04%	24
2015 Q3	$10.6M	Buy	355,210 +47	+0%	+$1.51K	1.48%	15
2015 Q2	$11.2M	Buy	355,163 +9,616	+3%	+$313K	1.43%	15
2015 Q1	$11.4M	Sell	345,547 -1,651	-0.5%	-$52.5K	1.47%	17
2014 Q4	$10.3M	Buy	347,198 +3,352	+1%	+$96.1K	1.24%	21
2014 Q3	$9.65M	Buy	343,846 +7,653	+2%	+$215K	1.12%	22
2014 Q2	$9.6M	Buy	336,193 +3,885	+1%	+$111K	1.04%	22
2014 Q1	$10.1M	Buy	332,308 +845	+0.3%	+$25.2K	1.35%	20
2013 Q4	$9.63M	Buy	331,463 +7,241	+2%	+$211K	1.31%	21
2013 Q3	$8.84M	Sell	324,222 -3,062	-0.9%	-$83.3K	1.27%	21
2013 Q2	$8.8M	Buy	+327,284	New	+$9.04M	1.3%	20

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Bank of Nova Scotia Trust's PFE Position: Q1 2026 in Review

Bank of Nova Scotia Trust increased its Pfizer (PFE) stake by 33% in Q1 2026, buying an estimated $70.8K and bringing the position to 10,773 shares worth $303K. The position accounts for 0.03% of the portfolio, ranked #133.

Bank of Nova Scotia Trust first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $11.4M in Q1 2015. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Bank of Nova Scotia Trust held 10,773 shares of Pfizer worth $303K as of Q1 2026.
Bank of Nova Scotia Trust bought 2,659 Pfizer shares in Q1 2026, an estimated $70.8K.
Pfizer made up 0.03% of Bank of Nova Scotia Trust's portfolio in Q1 2026, its #133 holding.
Bank of Nova Scotia Trust first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
Bank of Nova Scotia Trust's Pfizer position peaked at $11.4M in Q1 2015.
2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Bank of Nova Scotia Trust's 13F filing for Q1 2026, filed 13 May 2026.